Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ULTRALIFE CORPULBI · Entity 6735 | Director | November 24, 2025 | November 26, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ULTRALIFE CORP
Report date November 24, 2025 · Filed November 26, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock; $.10 par valueSEC Table I · non-derivative | Direct | 71,000 |
Reported balance
After 2025-11-24 transaction · row 1
1 source rowRow 1 · 2025-11-24 · Purchase · Acquired 1,750 · Balance 71,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 24, 2025 Filed Nov 26, 2025 14:58 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,750 | $5.67 | $9,922.50 |
DisclosureSEC source: 0001437749-25-036397 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,000 Read SEC document |
| May 14, 2025 Filed May 14, 2025 17:37 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 4,000 | $5.49 | $21,960.00 |
DisclosureSEC source: 0001437749-25-016753 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,250 Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 21:53 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,500 | $7.91 | $19,775.00 |
DisclosureSEC source: 0001437749-24-034590 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,250 Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 12:28 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,000 | $10.29 | $20,580.00 |
DisclosureSEC source: 0001437749-23-025961 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,750 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 15:46 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 3,000 | $5.10 | $15,300.00 |
DisclosureSEC source: 0001437749-22-002672 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,750 Read SEC document |
| February 25, 2021 Filed Feb 25, 2021 17:22 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,750 | $7.12 | $12,460.00 |
DisclosureSEC source: 0001437749-21-004036 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,750 Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 14:32 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,500 | $6.41 | $16,025.00 |
DisclosureSEC source: 0001437749-20-018425 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Read SEC document |
| May 13, 2019 Filed May 13, 2019 18:08 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,500 | $8.38 | $12,570.00 |
DisclosureSEC source: 0001437749-19-009622 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 16:31 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,000 | $7.01 | $14,020.00 |
DisclosureSEC source: 0001437749-18-022083 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 19:08 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,720 | $6.65 | $11,438.00 |
DisclosureSEC source: 0001437749-17-018510 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 19:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 2,000 | $6.55 | $13,100.00 |
DisclosureSEC source: 0001437749-17-010462 · rdgdoc.xml · nonDerivative · entry 1 Robert W. Shaw · CIK 0001493772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,280 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.